Antiplatelet agents reduce risks for death, stroke, myocardial infarction, deep venous thrombosis, and arterial occlusion
Publication
, Journal Article
Simel, DL
Published in: Annals of Internal Medicine
January 1, 1994
Duke Scholars
Published In
Annals of Internal Medicine
ISSN
0003-4819
Publication Date
January 1, 1994
Volume
121
Issue
SUPPL. 1
Start / End Page
4 / 6
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Simel, D. L. (1994). Antiplatelet agents reduce risks for death, stroke, myocardial infarction, deep venous thrombosis, and arterial occlusion. Annals of Internal Medicine, 121(SUPPL. 1), 4–6.
Simel, D. L. “Antiplatelet agents reduce risks for death, stroke, myocardial infarction, deep venous thrombosis, and arterial occlusion.” Annals of Internal Medicine 121, no. SUPPL. 1 (January 1, 1994): 4–6.
Simel DL. Antiplatelet agents reduce risks for death, stroke, myocardial infarction, deep venous thrombosis, and arterial occlusion. Annals of Internal Medicine. 1994 Jan 1;121(SUPPL. 1):4–6.
Simel, D. L. “Antiplatelet agents reduce risks for death, stroke, myocardial infarction, deep venous thrombosis, and arterial occlusion.” Annals of Internal Medicine, vol. 121, no. SUPPL. 1, Jan. 1994, pp. 4–6.
Simel DL. Antiplatelet agents reduce risks for death, stroke, myocardial infarction, deep venous thrombosis, and arterial occlusion. Annals of Internal Medicine. 1994 Jan 1;121(SUPPL. 1):4–6.
Published In
Annals of Internal Medicine
ISSN
0003-4819
Publication Date
January 1, 1994
Volume
121
Issue
SUPPL. 1
Start / End Page
4 / 6
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 11 Medical and Health Sciences